ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Passive

      Invesco Pharmaceuticals ETF

      The Invesco Pharmaceuticals ETF (the ¡°Fund¡±) seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical Intellidex??Index (the ¡°Underlying Index¡±).

      $92.79

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      Pharmaceuticals ETF PJP
      Fund Size
      $299M
      Dividend
      1.1%
      Fees
      -
      Total Stock Market Index Fund VTSAX
      Fund Size
      $1.7T
      Dividend
      -
      Fees
      -
      Total Stock Market Index Fund VTI
      Fund Size
      $1.7T
      Dividend
      1.2%
      Fees
      0.03%
      500 Index Fund VFIAX
      Fund Size
      $1.49T
      Dividend
      -
      Fees
      -
      500 Index Fund VOO
      Fund Size
      $1.49T
      Dividend
      1.2%
      Fees
      0.03%
      View 1315 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $137B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.43 %
      Beta Indicates the relationship between the price performance of a share and the market. 0.5469
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 35.91
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -85.69
      Profitable Companies 73
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 807.33
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.27
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 9.21
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT 25.49
      Enterprise Value to Revenue Enterprise value divided by revenue 69.09
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.19
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.4759
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -1218.27%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. 21.71%
      Return on Assets Indicates a company's profitability in relation to its total assets. 4.34%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 9.85%

      Industries

      Healthcare 82.9%
      Finance 2.9%
      N/A 14.3%

      Market cap

      Micro Cap 0%
      Small Cap 20%
      Mid Cap 21%
      Large Cap 29%
      Mega Cap 30%

      35 Investments

      P/E-Ratio
      Total Investment
      Weight
      Invesco Private Prime Fund logo

      Invesco Private Prime Fund

      P/E-Ratio
      n/a
      Total Investment
      $39.4M
      Weight
      16.2%
      Invesco Private Government Fund logo

      Invesco Private Government Fund

      P/E-Ratio
      n/a
      Total Investment
      $15.2M
      Weight
      6.2%
      Eli Lilly and Co. logo

      LLY - Manufacturing

      Eli Lilly and Co.

      P/E-Ratio
      47.7
      Total Investment
      $12.9M
      Weight
      5.3%
      Abbott Laboratories logo

      ABT - Manufacturing

      Abbott Laboratories

      P/E-Ratio
      16.5
      Total Investment
      $12.5M
      Weight
      5.1%
      AbbVie Inc. logo

      ABBV - Manufacturing

      AbbVie Inc.

      P/E-Ratio
      98.9
      Total Investment
      $12.4M
      Weight
      5.1%
      Gilead Sciences, Inc. logo

      GILD - Manufacturing

      Gilead Sciences, Inc.

      P/E-Ratio
      22.3
      Total Investment
      $12.4M
      Weight
      5.1%
      Johnson & Johnson logo

      JNJ - Manufacturing

      Johnson & Johnson

      P/E-Ratio
      18.9
      Total Investment
      $12.2M
      Weight
      5.0%
      Merck & Co., Inc. logo

      MRK - Manufacturing

      Merck & Co., Inc.

      P/E-Ratio
      12.9
      Total Investment
      $12.1M
      Weight
      5.0%
      Amgen Inc. logo

      AMGN - Manufacturing

      Amgen Inc.

      P/E-Ratio
      23.4
      Total Investment
      $11.9M
      Weight
      4.9%
      Pfizer Inc. logo

      PFE - Manufacturing

      Pfizer Inc.

      P/E-Ratio
      13.1
      Total Investment
      $11.8M
      Weight
      4.9%
      ANI Pharmaceuticals, Inc. logo

      ANIP - Manufacturing

      ANI Pharmaceuticals, Inc.

      P/E-Ratio
      -168.1
      Total Investment
      $9.18M
      Weight
      3.8%
      Tarsus Pharmaceuticals, Inc. logo

      TARS - Manufacturing

      Tarsus Pharmaceuticals, Inc.

      P/E-Ratio
      -8.5
      Total Investment
      $8.89M
      Weight
      3.6%
      Corcept Therapeutics Inc. logo

      CORT - Manufacturing

      Corcept Therapeutics Inc.

      P/E-Ratio
      54.8
      Total Investment
      $8.3M
      Weight
      3.4%
      Pacira Biosciences, Inc. logo

      Pacira Biosciences, Inc.

      P/E-Ratio
      n/a
      Total Investment
      $7.58M
      Weight
      3.1%
      Innoviva, Inc. logo

      INVA - Manufacturing

      Innoviva, Inc.

      P/E-Ratio
      33.2
      Total Investment
      $7.33M
      Weight
      3.0%
      Perrigo Co. PLC logo

      PRGO - Manufacturing

      Perrigo Co. PLC

      P/E-Ratio
      -40.9
      Total Investment
      $7.21M
      Weight
      3.0%
      Travere Therapeutics, Inc. logo

      TVTX - Manufacturing

      Travere Therapeutics, Inc.

      P/E-Ratio
      -9.2
      Total Investment
      $7.12M
      Weight
      2.9%
      Supernus Pharmaceuticals, Inc. logo

      SUPN - Manufacturing

      Supernus Pharmaceuticals, Inc.

      P/E-Ratio
      39.2
      Total Investment
      $7M
      Weight
      2.9%
      Collegium Pharmaceutical, Inc. logo

      COLL - Manufacturing

      Collegium Pharmaceutical, Inc.

      P/E-Ratio
      34.0
      Total Investment
      $6.62M
      Weight
      2.7%
      Prestige Consumer Healthcare Inc. logo

      PBH - Manufacturing

      Prestige Consumer Healthcare Inc.

      P/E-Ratio
      15.8
      Total Investment
      $6.57M
      Weight
      2.7%
      Ligand Pharmaceuticals Inc. logo

      LGND - Manufacturing

      Ligand Pharmaceuticals Inc.

      P/E-Ratio
      -41.1
      Total Investment
      $6.54M
      Weight
      2.7%
      Liquidia Corp. logo

      LQDA - Manufacturing

      Liquidia Corp.

      P/E-Ratio
      -23.7
      Total Investment
      $6.39M
      Weight
      2.6%
      Amneal Pharmaceuticals, Inc. logo

      AMRX - Manufacturing

      Amneal Pharmaceuticals, Inc.

      P/E-Ratio
      888.7
      Total Investment
      $6.37M
      Weight
      2.6%
      Bristol-Myers Squibb Co. logo

      BMY - Manufacturing

      Bristol-Myers Squibb Co.

      P/E-Ratio
      -16.7
      Total Investment
      $6.09M
      Weight
      2.5%
      United Therapeutics Corp. logo

      UTHR - Manufacturing

      United Therapeutics Corp.

      P/E-Ratio
      11.1
      Total Investment
      $5.99M
      Weight
      2.5%
      HoMEÔçÒÒŮѸÀ×